why choose us

First received: March 03, 2023

Clinical Trial: Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Glioblastoma

Study Type: INTERVENTIONAL


Official Title: A Single-Dose Study of Orally Administrated Defactinib or VS-6766 in Patients With Glioblastoma

Brief Summary: This early phase I trial tests brain concentration level and safety of defactinib or VS-6766 for the treatment of patients with glioblastoma.Recently, two new drugs that seem to work together have been shown to have promising treatment effects in tissue culture and animal models of glioblastoma.Each inhibits a different glioblastoma growth pathway and when used together may create a larger effect on tumor growth than either alone.Growth pathway describes a series of chemical reactions in which a group of molecules…

Read more